Perspective
Published on 27 Feb 2020
Management Strategies for POSEIDON Group 2
in Reproduction
Frontiers in Endocrinology
doi 10.3389/fendo.2020.00105
- 7,906 views
- 18 citations
21 articles related to "Poseidon Group"
Articles
Original Research
Published on 30 Mar 2023
Cumulative live birth rates and birth outcomes after IVF/ICSI treatment cycles in young POSEIDON patients: A real-world study
in Reproduction
Frontiers in Endocrinology
doi 10.3389/fendo.2023.1107406
- 4,806 views
- 10 citations
Clinical Trial
Published on 13 Sep 2021
Comparison of the Cumulative Live Birth Rates of Progestin-Primed Ovarian Stimulation and Flexible GnRH Antagonist Protocols in Patients With Low Prognosis
in Reproduction
Frontiers in Endocrinology
doi 10.3389/fendo.2021.705264
- 6,356 views
- 41 citations
Original Research
Published on 15 Nov 2019
Dehydroepiandrosterone Supplementation Improves the Outcomes of in vitro Fertilization Cycles in Older Patients With Diminished Ovarian Reserve
in Reproduction
Frontiers in Endocrinology
doi 10.3389/fendo.2019.00800
- 13,555 views
- 24 citations
Original Research
Published on 28 May 2024
Live birth rate per fresh embryo transfer and cumulative live birth rate in patients with PCOS under the POSEIDON classification: a retrospective study
in Reproduction
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1348771
- 4,153 views
- 4 citations
Policy and Practice Reviews
Published on 07 Feb 2024
Subtle perturbations of ovarian steroidogenesis in patients classified as Poseidon Group 3. Which consequences for therapeutic strategy?
in Reproduction
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1231585
- 2,209 views
- 3 citations
Original Research
Published on 13 Oct 2025
Analysis of factors associated with IVF/ICSI clinical outcomes in advanced maternal age patients with normal ovarian reserve under the POSEIDON criteria
in Reproduction
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1665922
- 1,701 views
Original Research
Published on 12 Nov 2019
The Effect of Growth Hormone on the Clinical Outcomes of Poor Ovarian Reserve Patients Undergoing in vitro Fertilization/Intracytoplasmic Sperm Injection Treatment: A Retrospective Study Based on POSEIDON Criteria
in Reproduction
Frontiers in Endocrinology
doi 10.3389/fendo.2019.00775
- 11,341 views
- 34 citations
Review
Published on 11 Sep 2019
Management Strategies for POSEIDON Groups 3 and 4
in Reproduction
Frontiers in Endocrinology
doi 10.3389/fendo.2019.00614
- 21,053 views
- 65 citations
Original Research
Published on 01 Dec 2021
The Livebirth Rate Per In Vitro Fertilization Cycle Is Higher Than The Cumulative Live Birth Rates of Intrauterine Insemination for Patients of Poseidon Group 3 With Unexplained Infertility
in Reproduction
Frontiers in Endocrinology
doi 10.3389/fendo.2021.768975
- 6,786 views
- 11 citations
Original Research
Published on 14 Jan 2022
Co-Administration of Clomiphene Citrate and Letrozole in Mild Ovarian Stimulation Versus Conventional Controlled Ovarian Stimulation Among POSEIDON Group 4 Patients
in Reproduction
Frontiers in Endocrinology
doi 10.3389/fendo.2021.780392
- 7,896 views
- 13 citations
Original Research
Published on 09 Nov 2023
Comparison between the modified long gonadotropin-releasing hormone agonist protocol and the non-downregulation protocol in POSEIDON groups: a propensity score matching retrospective cohort study
in Reproduction
Frontiers in Endocrinology
doi 10.3389/fendo.2023.1189357
- 3,118 views
- 3 citations
Perspective
Published on 20 Nov 2019
The POSEIDON Criteria and Its Measure of Success Through the Eyes of Clinicians and Embryologists
in Reproduction
Frontiers in Endocrinology
doi 10.3389/fendo.2019.00814
- 51,320 views
- 106 citations
Clinical Trial
Published on 04 Dec 2020
Comparative Effectiveness of Mild or Conventional GnRH-Antagonist Protocols for Ovarian Stimulation in Poor Responders (Poseidon Group 4)
in Assisted Reproduction
Frontiers in Reproductive Health
doi 10.3389/frph.2020.606036
- 5,555 views
- 5 citations
Clinical Trial
Published on 17 Jun 2021
The Role of Traditional Chinese Formula Ding-Kun Pill (DKP) in Expected Poor Ovarian Response Women (POSEIDON Group 4) Undergoing In Vitro Fertilization-Embryo Transfer: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
in Reproduction
Frontiers in Endocrinology
doi 10.3389/fendo.2021.675997
- 11,953 views
- 22 citations
Mini Review
Published on 08 May 2019
Ovarian Reserve Markers to Identify Poor Responders in the Context of Poseidon Classification
in Reproduction
Frontiers in Endocrinology
doi 10.3389/fendo.2019.00281
- 21,513 views
- 90 citations